当前位置:首页 - 行情中心 - 苑东生物(688513) - 财务分析 - 现金流量表

苑东生物

(688513)

  

流通市值:111.67亿  总市值:111.67亿
流通股本:1.77亿   总股本:1.77亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金393,132,334.511,424,877,392.911,099,079,014.31740,212,954.98
  收到的税费返还18,071.981,260,204.56903,364.0244,867.25
  收到其他与经营活动有关的现金17,111,959.2487,118,204.8959,931,204.4742,655,401.24
  经营活动现金流入小计410,262,365.731,513,255,802.361,159,913,582.8782,913,223.47
  购买商品、接受劳务支付的现金59,944,335.4253,854,280.7201,109,790.85120,227,395.01
  支付给职工以及为职工支付的现金97,715,221.5316,874,640.1248,916,233.01177,142,813.26
  支付的各项税费45,484,532.23156,130,319.55103,803,434.3872,084,393.3
  支付其他与经营活动有关的现金111,562,705.93521,455,357.79387,265,933.86255,985,963.4
  经营活动现金流出小计314,706,795.061,248,314,598.14941,095,392.1625,440,564.97
  经营活动产生的现金流量净额95,555,570.67264,941,204.22218,818,190.7157,472,658.5
二、投资活动产生的现金流量:
  取得投资收益收到的现金376,353.46---
  处置固定资产、无形资产和其他长期资产收回的现金净额36,139.96408,226.011,452,140.551,370,128.38
  收到的其他与投资活动有关的现金424,711,356.271,331,410,951.42625,174,486.68614,130,682.91
  投资活动现金流入小计425,123,849.691,331,819,177.43626,626,627.23615,500,811.29
  购建固定资产、无形资产和其他长期资产支付的现金17,065,958.6986,283,090.3257,026,332.932,724,421.83
  投资支付的现金6,000,00019,680,00019,680,000-
  支付其他与投资活动有关的现金955,676,299.081,592,307,945.861,136,113,471.66880,698,104.99
  投资活动现金流出小计978,742,257.771,698,271,036.181,212,819,804.56913,422,526.82
  投资活动产生的现金流量净额-553,618,408.08-366,451,858.75-586,193,177.33-297,921,715.53
三、筹资活动产生的现金流量:
  吸收投资收到的现金-9,536,983.689,536,983.689,536,983.68
  取得借款收到的现金-55,000,00035,000,00035,000,000
  收到其他与筹资活动有关的现金8,289,443.67140,973,498.73135,749,961.385,477,714.87
  筹资活动现金流入小计8,289,443.67205,510,482.41180,286,944.98130,014,698.55
  偿还债务支付的现金30,000,00073,666,666.6771,466,666.6771,466,666.67
  分配股利、利润或偿付利息支付的现金403,013.8876,787,844.9876,727,234.4276,151,625.18
  支付其他与筹资活动有关的现金44,156,772.3381,375,471.2269,699,657.394,454,116.42
  筹资活动现金流出小计74,559,786.21231,829,982.87217,893,558.48152,072,408.27
  筹资活动产生的现金流量净额-66,270,342.54-26,319,500.46-37,606,613.5-22,057,709.72
四、汇率变动对现金及现金等价物的影响-423,703.76-470,178.96-194,430.12,612.23
五、现金及现金等价物净增加额-524,756,883.71-128,300,333.95-405,176,030.23-162,504,154.52
  加:期初现金及现金等价物余额836,878,171.24965,178,505.19965,178,505.19965,178,505.19
  期末现金及现金等价物余额312,121,287.53836,878,171.24560,002,474.96802,674,350.67
补充资料:
  净利润-273,573,868.43-136,571,926.08
  资产减值准备-4,372,647.11-1,079,831.19
  固定资产和投资性房地产折旧-85,764,580.82-40,141,829.21
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-85,764,580.82-40,141,829.21
  无形资产摊销-6,847,843.86-1,212,076.2
  长期待摊费用摊销-1,519,836.83-636,069.74
  处置固定资产、无形资产和其他长期资产的损失--29,348.33--
  固定资产报废损失-208,834.63-20,983.86
  公允价值变动损失--17,128,662.34--6,835,167.13
  财务费用-2,513,008.66-1,275,243.07
  投资损失--39,005,713.4--4,047,937.64
  递延所得税--9,462,087.7-1,850,656.37
  其中:递延所得税资产减少--9,415,057.41-1,339,583.11
    递延所得税负债增加--47,030.29-511,073.26
  存货的减少--38,709,027.19--25,638,050.98
  经营性应收项目的减少--23,857,960.11-28,915,103.3
  经营性应付项目的增加-6,961,462.61--33,109,363.55
  其他-11,588,567.73-14,886,582.65
  现金的期末余额-836,878,171.24-802,674,350.67
  减:现金的期初余额-965,178,505.19-965,178,505.19
  现金及现金等价物的净增加额--128,300,333.95--162,504,154.52
公告日期2026-04-222026-04-222025-10-282025-08-19
审计意见(境内)标准无保留意见
TOP↑